🇨🇦 Norepinephrine Bitartrate In 5% Dextrose in Canada

Norepinephrine Bitartrate In 5% Dextrose (NOREPINEPHRINE) regulatory status in Canada.

Marketing authorisation

Norepinephrine Bitartrate In 5% Dextrose in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Cardiovascular approved in Canada

Frequently asked questions

Is Norepinephrine Bitartrate In 5% Dextrose approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for Norepinephrine Bitartrate In 5% Dextrose in Canada?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.